top of page
-
Leveraging Access Programs Across Brand Lifecycle to Optimize Patient Reach
Mr. Varun Gupta (Value and Access, Director- International, Novartis AG)
-
Evolving role of Value and Access in early pipeline assessments.
Ms. Pooja Desai (Global Early Market Access- Immunology, Novartis, New York City, USA)
-
Role of Clinical trial design in supporting access & reimbursement
Mr. Sanchit Nanda (Head Strategic Partnerships - Torrent Pharmaceuticals Ltd. | Former Senior Director - Gilead Sciences)
Session 2 : Panel Discussion 1
Session 3 : Panel Discussion 2
Chairperson:
Shri A. K. Pradhan ( Former Joint Drug Controller (India), MoHFW, GoI)
Moderator :
Mr Tarun Gupta (Founder & CEO, VaidyaRx Pvt. Ltd.)
Closing Remarks
Shri A. K. Pradhan
-
Introduction to the Brainstorming
Prof. Y. K. Gupta (President, AIIMS Kalyani, Former President- AIIMS Bhopal, AIIMS Jammu; Former Dean AIIMS, Delhi & Founder of YKG Academy)
-
Address by President (Guest of Honour)
Prof. Digambar Behera, (President , NAMS, MoHFW, GoI)
Session 1: Introductory Session
Vote of Thanks
Mr. Tarun Gupta
Poll & Announcements
bottom of page